Advances in Gynecological Diseases

Guglielmo Stabile, Laura Vona, Stefano Restaino, Martina Arcieri, Luigi Nappi, Nappi L
Journal of clinical medicine · 2025 · vol. 14(19) · doi:10.3390/jcm14196988 · PMID:41096068 · PMC12525198
Review OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-28 ⓘ

This review examines recent technological, pharmacological, and biotechnological innovations that have transformed the diagnosis, management, and treatment of various gynecologic conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-22 · read from full text ⓘ

The provided text consists entirely of author contribution statements, conflict of interest declarations, and publisher disclaimers rather than the substantive content of a research study. It lacks any description of methodology, patient populations, clinical findings, or biological mechanisms typically found in scientific literature. Consequently, no specific medical conclusions or data points can be extracted from this excerpt for analysis. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

In recent decades, gynecology has undergone a profound transformation driven by technological, pharmacological, and biotechnological innovations that have fundamentally changed the diagnosis, management, and treatment of numerous gynecologic conditions [...].
Full text 847 characters · extracted from epmc-fulltextxml · 3 sections · click to expand

Author

Conceptualization, G.S., L.N. and L.V.; methodology, L.V. and G.S.; validation, S.R., M.A. and L.N.; formal analysis, G.S.; investigation, L.V.; resources, M.A. and S.R.; data curation, L.V.; writing—original draft preparation, L.V.; writing—review and editing, G.S., S.R. and M.A.; visualization, L.N.; supervision, L.N.; project administration, G.S. All authors have read and agreed to the published version of the manuscript.

Fn Group

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Conflicts

The authors declare no conflicts of interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
pubmed
last seen: 2026-10-08T21:52:07.191503+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC